Docoh
Loading...

33 results

Filter options loading...
Top filers
Top filing types
Recent filing years
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
. These increases were offset by a decrease of $15,727 in expenses such as travel, repairs and maintenance and training. Reimbursable expenses from
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
13 Oct 20
Processa Pharmaceuticals Announces Appointment of Michael Floyd as Chief Operating Officer
9:30am
with Employee’s training, experience, and qualifications. The terms and conditions of the Employee’s employment shall, to the extent not addressed
S-1/A
EX-10.4
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
duties shall be consistent with Employee’s training, experience, and qualifications. The terms and conditions of the Employee’s employment shall
S-1/A
PCSA Processa Pharmaceuticals Inc
17 Jul 20
IPO registration (amended)
5:25pm
as decreases in travel, utilities, training and repairs and maintenance of approximately $60,000. Reimbursements from CorLyst totaled $24,747 for rent
10-Q
2020 Q1
PCSA Processa Pharmaceuticals Inc
15 May 20
Quarterly report
1:23pm
by reductions in professional fees for legal, accounting, advisory and consulting costs, as well as decreases in travel, utilities, training and repairs
8-K
EX-99.1
PCSA Processa Pharmaceuticals Inc
5 Mar 20
Processa Pharmaceuticals Announces Formation of Its Medical and Scientific Advisory Board
9:30am
, regulatory affairs, and intellectual property. Dr. Devane received his B.Sc. Hons. and Ph.D scientific training at the University College in Dublin
S-1
PCSA Processa Pharmaceuticals Inc
13 Dec 19
IPO registration
5:32pm
that have undergone specialized training, limiting treatment to patients who meet certain safe-use criteria or requiring patient testing, monitoring
10-Q
2019 Q2
PCSA Processa Pharmaceuticals Inc
13 Aug 19
Quarterly report
8:00pm
-day period for the action to become effective. These increases were offset by decreases of approximately $10,000 in training, repairs and maintenance
10-K/A
2018 FY
PCSA Processa Pharmaceuticals Inc
5 Apr 19
Annual report (amended)
9:40pm
, such as limiting prescribing to certain physicians or medical centers that have undergone specialized training, limiting treatment to patients who meet
10-K
2018 FY
PCSA Processa Pharmaceuticals Inc
28 Mar 19
Annual report
5:25pm
, such as limiting prescribing to certain physicians or medical centers that have undergone specialized training, limiting treatment to patients who meet
424B3
PCSA Processa Pharmaceuticals Inc
9 Nov 18
Prospectus supplement
5:04pm
of an approved drug, such as limiting prescribing to certain physicians or medical centers that have undergone specialized training, limiting … , and the increase in other administrative costs such as training and repairs and maintenance of approximately $19,000, In the six months ended June 30, 2018
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Oct 18
IPO registration (amended)
4:19pm
undergone specialized training, limiting treatment to patients who meet certain safe-use criteria or requiring patient testing, monitoring and/or enrollment … insurance costs of approximately $12,000, and the increase in other administrative costs such as training and repairs and maintenance of approximately
S-1/A
PCSA Processa Pharmaceuticals Inc
9 Oct 18
IPO registration (amended)
5:32pm
, such as limiting prescribing to certain physicians or medical centers that have undergone specialized training, limiting treatment to patients who … administrative costs such as training and repairs and maintenance of approximately $19,000, In the six months ended June 30, 2018 compared to the same
S-1/A
PCSA Processa Pharmaceuticals Inc
13 Sep 18
IPO registration (amended)
8:00pm
physicians or medical centers that have undergone specialized training, limiting treatment to patients who meet certain safe-use criteria or requiring … costs of approximately $12,000, and the increase in other administrative costs such as training and repairs and maintenance of approximately $19,000
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
9 Sep 18
Departure of Directors or Certain Officers
8:00pm
duties shall be consistent with Employee’s training, experience, and qualifications. The terms and conditions of the Employee’s employment shall
10-Q
2018 Q2
PCSA Processa Pharmaceuticals Inc
14 Aug 18
Quarterly report
5:29pm
administrative costs such as training and repairs and maintenance of approximately $19,000, In the six months ended June 30, 2018 compared to the same … insurance costs of approximately $10,000; and the increase in other administrative costs such as travel and training of approximately $20,000. Cost
S-1
PCSA Processa Pharmaceuticals Inc
29 Jul 18
IPO registration
8:00pm
undergone specialized training, limiting treatment to patients who meet certain safe-use criteria or requiring patient testing, monitoring
10-K/A
2017 FY
PCSA Processa Pharmaceuticals Inc
16 Apr 18
Annual report (amended)
8:00pm
, such as limiting prescribing to certain physicians or medical centers that have undergone specialized training, limiting treatment to patients who meet certain
10-K
2017 FY
PCSA Processa Pharmaceuticals Inc
15 Apr 18
Annual report
8:00pm
or medical centers that have undergone specialized training, limiting treatment to patients who meet certain safe-use criteria or requiring patient
10-K
2016 FY
PCSA Processa Pharmaceuticals Inc
24 Sep 17
Annual report
8:00pm
into distribution agreements, licensing and franchising opportunities, and provide on-going education and training to our sales partners, customers